Louise Aberg focuses her practice on US, EU and French antitrust law, including merger control, cartels, and abuse of dominance. Louise also regularly advises clients in relation to distribution strategies and compliance programs. She represents clients before the Federal Trade Commission, the Department of Justice, the European Commission, and the French Competition Authority.
She has represented numerous clients in, among others, the automotive, life sciences, and telecommunications industries and has significant experience advising private equity companies.
In addition to her antitrust and competition practice, Louise also assists pharmaceutical companies in the preparation and negotiation of collaboration, license and distribution agreements.
Louise was recognized as one of 2017 ‘30 in their 30s’ Notable Women Competition Professionals in the Private Practice category by Women@Competition in association with PaRR.
Louise also maintains an active pro bono practice. She has notably assisted Lawyers Without Borders on projects aimed at strengthening enforcement in various African countries and the Human Dignity Trust in a case before the Court of Justice of the European Union.
Represented several international companies in cartel investigations before the French Competition Authority, the European Commission, the Paris Court of Appeal, and the Department of Justice, including in the context of settlement and leniency procedures
Assisted several international companies in the design and implementation of antitrust compliance programs
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.